-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Akari Therapeutics Plc quarterly/annual Interest Expense history and growth rate from Q3 2014 to Q2 2024.
- Akari Therapeutics Plc Interest Expense for the quarter ending June 30, 2024 was $51K.
- Akari Therapeutics Plc annual Interest Expense for 2017 was $0.000.
- Akari Therapeutics Plc annual Interest Expense for 2016 was $0.000, a 100% decline from 2015.
- Akari Therapeutics Plc annual Interest Expense for 2015 was $3.05K, a 43.8% decline from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)